KR840003422A - 균질한 인체 면역 인터페론의 제조방법 - Google Patents

균질한 인체 면역 인터페론의 제조방법 Download PDF

Info

Publication number
KR840003422A
KR840003422A KR1019830000822A KR830000822A KR840003422A KR 840003422 A KR840003422 A KR 840003422A KR 1019830000822 A KR1019830000822 A KR 1019830000822A KR 830000822 A KR830000822 A KR 830000822A KR 840003422 A KR840003422 A KR 840003422A
Authority
KR
South Korea
Prior art keywords
column
human immune
immune interferon
interferon
active fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019830000822A
Other languages
English (en)
Korean (ko)
Inventor
스타인 스탠리 (외 1)
Original Assignee
쿠르트 네젤보쉬, 한스 스튀클린
에프. 호프만 리-로슈 앤드 캄파니 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿠르트 네젤보쉬, 한스 스튀클린, 에프. 호프만 리-로슈 앤드 캄파니 아크티엔 게젤샤프트 filed Critical 쿠르트 네젤보쉬, 한스 스튀클린
Publication of KR840003422A publication Critical patent/KR840003422A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019830000822A 1982-03-01 1983-02-28 균질한 인체 면역 인터페론의 제조방법 Withdrawn KR840003422A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35344282A 1982-03-01 1982-03-01
US353442 1982-03-01

Publications (1)

Publication Number Publication Date
KR840003422A true KR840003422A (ko) 1984-09-08

Family

ID=23389118

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000822A Withdrawn KR840003422A (ko) 1982-03-01 1983-02-28 균질한 인체 면역 인터페론의 제조방법

Country Status (19)

Country Link
EP (1) EP0087686A3 (enExample)
JP (1) JPS58159417A (enExample)
KR (1) KR840003422A (enExample)
AU (1) AU1181283A (enExample)
DK (1) DK104283A (enExample)
ES (1) ES8407499A1 (enExample)
FI (1) FI830557A7 (enExample)
GB (1) GB2119383A (enExample)
GR (1) GR77910B (enExample)
GT (1) GT198301619A (enExample)
IL (1) IL67978A0 (enExample)
MC (1) MC1499A1 (enExample)
MT (1) MTP924B (enExample)
MW (1) MW783A1 (enExample)
NO (1) NO830697L (enExample)
NZ (1) NZ203364A (enExample)
PT (1) PT76310B (enExample)
ZA (1) ZA83768B (enExample)
ZW (1) ZW4683A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DK131986A (da) * 1985-03-25 1986-09-26 Schering Corp Stabilt gammainterferonpraeparat
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon
IL84170A0 (en) * 1986-10-17 1988-03-31 Interferon Sciences Inc Method for detecting interferon
EP0276120B1 (en) * 1987-01-20 1992-04-08 Schering Corporation Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA120527A (en) * 1907-05-18 1909-09-14 James Mccallum Robertson Prepay device for meters
CA120526A (en) * 1909-05-05 1909-09-14 Robert A. Reynolds Internal combustion engine
CA130300A (en) * 1910-08-03 1911-01-03 John W. Ziegler Current wheel
CA154712A (en) * 1914-01-02 1914-03-31 William Francis Fox Photographic process
CA179241A (en) * 1917-03-02 1917-09-11 John Totterdale Container
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Also Published As

Publication number Publication date
GR77910B (enExample) 1984-09-25
ZW4683A1 (en) 1983-10-19
FI830557A0 (fi) 1983-02-18
JPS58159417A (ja) 1983-09-21
DK104283A (da) 1983-09-02
FI830557L (fi) 1983-09-02
MTP924B (en) 1984-05-03
MC1499A1 (fr) 1983-11-17
ES520164A0 (es) 1984-10-01
IL67978A0 (en) 1983-06-15
ZA83768B (en) 1983-10-26
PT76310A (en) 1983-03-01
EP0087686A3 (en) 1985-09-18
NO830697L (no) 1983-09-02
GT198301619A (es) 1984-08-21
GB2119383A (en) 1983-11-16
AU1181283A (en) 1983-09-08
GB8305506D0 (en) 1983-03-30
PT76310B (en) 1986-02-12
DK104283D0 (da) 1983-02-28
FI830557A7 (fi) 1983-09-02
EP0087686A2 (en) 1983-09-07
NZ203364A (en) 1986-07-11
ES8407499A1 (es) 1984-10-01
MW783A1 (en) 1984-09-12

Similar Documents

Publication Publication Date Title
KR840003422A (ko) 균질한 인체 면역 인터페론의 제조방법
Riggs et al. A simple fractionation method for preparation of fluorescein-labeled gamma globulin.
JPS5740503A (en) Separation of saccharides
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
NZ210427A (en) Process for purifying blood clotting factor (factor viii:c); pharmaceutical compositions
ES2081742A1 (es) Procedimiento para preparar inmunoglobulina purificada.
ES8100502A1 (es) Un procedimiento para purificar proteinas con pesos moleculares superiores a 12.000,en particular interferon
KR870700006A (ko) 항혈우병 인자의 정제방법
EP0239565A3 (en) Method of and apparatus for separating proteins
Andersson Fractionation of human serum proteins by immobilized metal affinity chromatography
GB908333A (en) Method for the production of substantially protein-free callicrein
Ikehara et al. An improved method for the purification of rat serum albumin: removal of contaminants by concanavalin A-Sepharose
RU95112503A (ru) Способ выделения предварительно отобранного гемоглобина и очищенный препарат гемоглобина
NZ221346A (en) Preparation(purification)of somatomedin c
Matsumoto et al. Separation of isolectins by high-performance hydrophobic interaction chromatography
FI874431A0 (fi) Foerfarande foer rening av antikroppar.
KR910015699A (ko) 리포코틴의 정제방법
GB1313430A (en) Materials eluting method
KR860000868A (ko) Lpf-ha의 정제방법
KR970027103A (ko) 혈소판 인자-4의 제조 방법
KR960010682A (ko) 금속이온 친화성 크로마토그라피를 이용한 히루딘의 정제방법
Young et al. Chromatography of lysosomal enzymes on hydroxylapatite
KR860009034A (ko) 핵산 정제모액의 처리방법
KR830009779A (ko) 항종양 생리학적 활성물질의 정제방법
JPS5777960A (en) Affinitive adsorbent for affnity chromatography

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830228

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid